CDW (CDW): Time to Consider Put Options? AI Bearish Alert
AI-powered insights updated on 11/4/2025.
Price Trend
Below 50-day Moving Average
R S I Momentum
Weakening RSI
Volume Surge
High Volume
CDW Earnings Date & Key Events
| Date | Event | Type |
|---|---|---|
| 11/4/2025 | CDW Earnings | CDW-Specific |
Full Analysis Breakdown
CDW is a multi-brand provider of IT solutions to business, government, education, and healthcare customers in the US, UK, and Canada. The company offers a broad range of IT solutions, from discrete hardware and software products to integrated solutions and services encompassing on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. CDW serves over 250,000 customers through sales teams focused on specific end-markets, including corporate, small business, and public sectors. CDW differentiates itself by offering vendor, technology, and consumption model-unbiased solutions, acting as a trusted advisor and extension of its customers' IT workforce. This is accomplished through a multi-brand offering approach, leveraging partnerships with OEMs, software publishers, and cloud providers to provide solutions that best address customer-specific requirements.
No relevant news was found for this stock today.
CDW's technical outlook is decidedly bearish. The recent price action shows a sharp decline, with the most recent close at $142.09, significantly below the 50-day SMA of $160.23 and the 200-day SMA which is starting to be calculated at $170.77. The price has fallen below the lower Bollinger Band, suggesting oversold conditions, but the strong downward momentum indicates further potential declines. Momentum indicators confirm the bearish sentiment. The RSI is low at 45.94, and the MACD is deeply negative at -0.56, with the MACD line trending below the signal line. The Stochastic Oscillator is showing a recent crossover, but this signal is occurring in oversold territory, which may not be reliable. Overall, the combination of negative price action, bearish momentum indicators, and a break below key moving averages suggests a high probability of continued downward movement in the short to medium term. The ADX is weak however, suggesting the trend is not strong.
CDW's MD&A presents a slightly positive but nuanced outlook. For the three months ended September 30, 2025, `Net sales` increased by 4.0% to $5,737.4 million compared to $5,516.6 million in 2024. The `Gross profit` margin also slightly increased from 21.8% to 21.9%. However, for the nine months ended September 30, 2025, while `Net sales` increased by 7.0%, the `Gross profit` margin decreased from 21.8% to 21.4%. `Net cash provided by operating activities` decreased to $771.4 million for the nine months ended September 30, 2025, from $932.0 million in the prior year, primarily due to changes in accounts receivable and merchandise inventory. Management notes that 'economic and geopolitical uncertainty persists', impacting customer spending, but certain end-markets experienced improved spending. They also highlight the shift to multi-year software purchases, which is expected to increase unbilled receivables and accounts payable. The company's cash conversion cycle decreased to 11 days from 17 days, reflecting improved working capital management.
CDW's Q2 2025 earnings call presents a moderately bullish, albeit cautious, outlook. CEO Christine Leahy highlighted 'double-digit top line growth' despite headwinds in federal and education markets, emphasizing the strength of their 'full stack, full life cycle solutions.' Consolidated net sales were $6 billion, up 10%, with gross profit up 5%. While maintaining their 2025 outlook for low single-digit IT market growth, CDW aims for a 200-300 basis point premium. CFO Al Miralles noted that gross margin of 20.8% was down year-over-year due to customer and product mix, particularly a 'higher contribution from large corporate customers.' Management expressed prudence regarding the back half of the year, citing continued challenges in government and education sectors, though they also noted that the team's execution has been 'very spot on' in terms of working with customers. While not explicitly raising guidance, the strong first half and positive trends in areas like AI and enterprise solutions suggest a cautiously optimistic outlook.
CDW's financial performance presents a somewhat positive but mixed picture. Revenue has generally increased, from $4.87B in Q1 2024 to $5.74B in Q3 2025, indicating growth in sales. The gross profit ratio has remained relatively stable, fluctuating between 0.215 and 0.230, suggesting consistent profitability on sales. Operating cash flow has varied across the quarters, with the latest quarter (Q3 2025) showing $328.3M, indicating positive cash generation from operations. Total debt has fluctuated, starting at $5.80B in Q1 2024 and ending at $5.76B in Q3 2025, suggesting a relatively stable debt level. While revenue is growing and debt is being managed, the volatility in operating cash flow and gross profit ratio requires further monitoring to ensure sustained financial health. Overall, CDW appears to be in a moderately stable position, but the inconsistent cash flow performance warrants attention.
The company presents a moderately bullish investment profile based on its financial data. Revenue has shown positive growth, indicating increasing market demand or successful market penetration. The gross margin is healthy, suggesting efficient cost management in production or service delivery. A strong return on equity (ROE) signals effective utilization of shareholder investments to generate profit. The price-to-earnings (P/E) ratio suggests the stock is trading at a premium, but this could be justified by the company's growth prospects and profitability. A manageable debt-to-equity ratio indicates a reasonable level of financial leverage. The current ratio, being greater than 1, demonstrates the company's ability to cover short-term liabilities with its current assets, further solidifying its financial health. Overall, the combination of revenue growth, healthy profitability metrics, and a solid balance sheet makes the company an attractive investment for the next 12 months, although the elevated P/E ratio warrants careful monitoring.
The information provided on this page is for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice and you should not treat any of the page's content as such. ProfitScout does not recommend that any security should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions.